NCT05675722View on ClinicalTrials.gov

Implantation Of Vaginal Construct For Patients With Vaginal Aplasia

PHASE1RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2029

Conditions
Congenital Mullerian Duct Anomaly
Interventions
BIOLOGICAL

biologic vaginal-construct implantation

biologic Tissue Engineered Vagina (TEV), which provides an epithelial layer for the luminal aspect and a smooth muscle layer for protecting the openness of the hollow tube, mimicking the cellular orientation and architecture of the vagina. Autologous cells isolated from vagina/vulva remnants offset any potential for immunological rejection.

Trial Locations (1)

27157

RECRUITING

Wake Forest University Health Sciences, Winston-Salem

All Listed Sponsors
lead

Wake Forest University Health Sciences

OTHER

NCT05675722 - Implantation Of Vaginal Construct For Patients With Vaginal Aplasia | Biotech Hunter | Biotech Hunter